Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Aug 21, 2015 (11 years ago)

Atropine Sulfate Injection Solution

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Subpotent Drug

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453

Affected NDC 52533-0010-45

Compare with the code on your package — it is the most precise check available.

Drug: Atropine

Recalling firm
Cantrell Drug Company
NDC code
52533-010-45
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1153-2016 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Atropine recalls

See all
Class II · Moderate risk

Atropine Sulfate injection

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Ongoing Particulate / foreign matter American Regent, Inc. NDC 0517-1001-01 D-0795-2026

Other recalls by Cantrell Drug Company

All 2015 recalls